BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 27044819)

  • 1. Pristimerin inhibits proliferation, migration and invasion, and induces apoptosis in HCT-116 colorectal cancer cells.
    Yousef BA; Hassan HM; Guerram M; Hamdi AM; Wang B; Zhang LY; Jiang ZZ
    Biomed Pharmacother; 2016 Apr; 79():112-9. PubMed ID: 27044819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pristimerin exhibits in vitro and in vivo anticancer activities through inhibition of nuclear factor-кB signaling pathway in colorectal cancer cells.
    Yousef BA; Hassan HM; Zhang LY; Jiang ZZ
    Phytomedicine; 2018 Feb; 40():140-147. PubMed ID: 29496166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pristimerin on apoptosis through activation of ROS/ endoplasmic reticulum (ER) stress-mediated noxa in colorectal cancer.
    Zhao Q; Bi Y; Guo J; Liu Y; Zhong J; Liu Y; Pan L; Guo Y; Tan Y; Yu X
    Phytomedicine; 2021 Jan; 80():153399. PubMed ID: 33202325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pristimerin targeting NF-κB pathway inhibits proliferation, migration, and invasion in esophageal squamous cell carcinoma cells.
    Tu Y; Tan F; Zhou J; Pan J
    Cell Biochem Funct; 2018 Jun; 36(4):228-240. PubMed ID: 29781107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pristimerin demonstrates anticancer potential in colorectal cancer cells by inducing G1 phase arrest and apoptosis and suppressing various pro-survival signaling proteins.
    Yousef BA; Guerram M; Hassan HM; Hamdi AM; Zhang LY; Jiang ZZ
    Oncol Rep; 2016 Feb; 35(2):1091-100. PubMed ID: 26718323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coptisine-induced apoptosis in human colon cancer cells (HCT-116) is mediated by PI3K/Akt and mitochondrial-associated apoptotic pathway.
    Han B; Jiang P; Li Z; Yu Y; Huang T; Ye X; Li X
    Phytomedicine; 2018 Sep; 48():152-160. PubMed ID: 30195873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triterpenoid pristimerin induced HepG2 cells apoptosis through ROS-mediated mitochondrial dysfunction.
    Guo Y; Zhang W; Yan YY; Ma CG; Wang X; Wang C; Zhao JL
    J BUON; 2013; 18(2):477-85. PubMed ID: 23818365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lycorine inhibits cell proliferation, migration and invasion, and primarily exerts
    Zhang P; Yuan X; Yu T; Huang H; Yang C; Zhang L; Yang S; Luo X; Luo J
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delicaflavone induces ROS-mediated apoptosis and inhibits PI3K/AKT/mTOR and Ras/MEK/Erk signaling pathways in colorectal cancer cells.
    Yao W; Lin Z; Shi P; Chen B; Wang G; Huang J; Sui Y; Liu Q; Li S; Lin X; Liu Q; Yao H
    Biochem Pharmacol; 2020 Jan; 171():113680. PubMed ID: 31669234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity in colorectal cancer induced by hinokiflavone.
    Zhou J; Zhao R; Ye T; Yang S; Li Y; Yang F; Wang G; Xie Y; Li Q
    J Gastroenterol Hepatol; 2019 Sep; 34(9):1571-1580. PubMed ID: 30575109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticolorectal Cancer Effects of AUCAN: Effects to Suppress Proliferation, Metastasis, and Invasion of Tumor Cells.
    Xiong LL; Du RL; Chen JJ; Jiang Y; Xue LL; Niu RZ; Chen L; Liu J; Wang TH
    Biomed Res Int; 2020; 2020():9786428. PubMed ID: 33102601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol elicits anti-colorectal cancer effect by activating miR-34c-KITLG in vitro and in vivo.
    Yang S; Li W; Sun H; Wu B; Ji F; Sun T; Chang H; Shen P; Wang Y; Zhou D
    BMC Cancer; 2015 Dec; 15():969. PubMed ID: 26674205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cucurbitacin B controls M2 macrophage polarization to suppresses metastasis via targeting JAK-2/STAT3 signalling pathway in colorectal cancer.
    Zhang H; Zhao B; Wei H; Zeng H; Sheng D; Zhang Y
    J Ethnopharmacol; 2022 Apr; 287():114915. PubMed ID: 34954267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A438079 affects colorectal cancer cell proliferation, migration, apoptosis, and pyroptosis by inhibiting the P2X7 receptor.
    Zhang Y; Li F; Wang L; Lou Y
    Biochem Biophys Res Commun; 2021 Jun; 558():147-153. PubMed ID: 33915328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel derivative of aminobenzenesulfonamide (3c) induces apoptosis in colorectal cancer cells through ROS generation and inhibits cell migration.
    Al-Khayal K; Alafeefy A; Vaali-Mohammed MA; Mahmood A; Zubaidi A; Al-Obeed O; Khan Z; Abdulla M; Ahmad R
    BMC Cancer; 2017 Jan; 17(1):4. PubMed ID: 28049506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pristimerin inhibits breast cancer cell migration by up- regulating regulator of G protein signaling 4 expression.
    Mu XM; Shi W; Sun LX; Li H; Wang YR; Jiang ZZ; Zhang LY
    Asian Pac J Cancer Prev; 2012; 13(4):1097-104. PubMed ID: 22799288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl-2-associated athanogene 3(BAG3) is associated with tumor cell proliferation, migration, invasion and chemoresistance in colorectal cancer.
    Li N; Chen M; Cao Y; Li H; Zhao J; Zhai Z; Ren F; Li K
    BMC Cancer; 2018 Aug; 18(1):793. PubMed ID: 30081850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A promising natural product, pristimerin, results in cytotoxicity against breast cancer stem cells in vitro and xenografts in vivo through apoptosis and an incomplete autopaghy in breast cancer.
    Cevatemre B; Erkısa M; Aztopal N; Karakas D; Alper P; Tsimplouli C; Sereti E; Dimas K; Armutak EII; Gurevin EG; Uvez A; Mori M; Berardozzi S; Ingallina C; D'Acquarica I; Botta B; Ozpolat B; Ulukaya E
    Pharmacol Res; 2018 Mar; 129():500-514. PubMed ID: 29197639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer Potential and Molecular Targets of Pristimerin: A Mini- Review.
    Yousef BA; Hassan HM; Zhang LY; Jiang ZZ
    Curr Cancer Drug Targets; 2017; 17(2):100-108. PubMed ID: 26758533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ursolic acid inhibits colorectal cancer angiogenesis through suppression of multiple signaling pathways.
    Lin J; Chen Y; Wei L; Hong Z; Sferra TJ; Peng J
    Int J Oncol; 2013 Nov; 43(5):1666-74. PubMed ID: 24042330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.